Financial statements Santepharm
Balance sheet data of SANTEPHARM
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|---|
| Total assets | 553 242,31 | 5 697 677,56 | 8 573 993,83 | 1 866 810,08 | 40 058,66 |
| A. Fixed assets | 66 453,70 | 0,00 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 486 788,61 | 5 697 677,56 | 8 573 993,83 | 1 866 810,08 | 40 058,66 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 553 242,31 | 5 697 677,56 | 8 573 993,83 | 1 866 810,08 | 40 058,66 |
| A. Equity | 547 155,11 | 5 690 662,82 | 8 573 993,83 | 1 866 810,08 | 35 430,88 |
| B. Liabilities and provisions for liabilities | 6 087,20 | 7 014,74 | 0,00 | 0,00 | 4 627,78 |
| I. Long-term liabilities | - | - | - | - | - |
| II. Short-term liabilities | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.